tiprankstipranks
Matinas BioPharma (MTNB)
:MTNB
US Market

Matinas BioPharma (MTNB) Income Statement

Compare
1,523 Followers

Matinas BioPharma Income Statement

Last quarter (Q3 2024), Matinas BioPharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Matinas BioPharma's net income was $-4.28M. See Matinas BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.10M$ 3.19M$ 33.33K$ 158.33K$ 90.00K
Gross Profit
$ -13.39M$ -13.49M$ -748.16K$ -14.20M$ -11.14M
Operating Expenses
$ 24.86M$ 11.10M$ 24.77M$ 24.36M$ 19.01M
Depreciation and Amortization
$ 941.00K$ 898.00K$ 781.49K$ 774.59K$ 780.82K
EBITDA
$ -22.82M$ -24.23M$ -24.45M$ -23.92M$ -18.59M
Operating Income
$ -23.77M$ -24.59M$ -24.73M$ -24.21M$ -18.92M
Other Income/Expenses
$ 824.00K$ 3.59M$ 1.45M$ 1.76M$ 1.55M
Pretax Income
$ -22.94M$ -21.00M$ -23.28M$ -22.45M$ -17.37M
Net Income
$ -22.94M$ -13.02M$ -21.17M$ -20.60M$ -15.59M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.28$ -3.00$ -5.04$ -5.23$ -5.37
Diluted EPS
$ -5.28$ -3.00$ -5.04$ -5.23$ -5.37
Weighted Average Shares Outstanding
4.35M----
Weighted Average Shares Outstanding (Diluted)
4.35M----
Currency in USD

Matinas BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis